Cure-in Inc. (co-CEOs Yung-Ho Jo and Samuel Byeongjun Park), a medical robotics company founded in 2020 by a research team from the Department of Biomedical Engineering at the National Cancer Center, aims to offer trust to medical professionals and comfort to patients.
